Author: Sim Michael W Cohen Mark Steven
Publisher: Informa Healthcare
ISSN: 1746-0441
Source: Expert Opinion on Drug Discovery, Vol.9, Iss.1, 2014-01, pp. : 105-114
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Vandetanib: In Medullary Thyroid Cancer
Drugs, Vol. 72, Iss. 10, 2012-07 ,pp. :
Vandetanib for the treatment of lung cancer
By Chu Caleb T Sada Yvonne H Kim Edward S
Expert Opinion on Investigational Drugs, Vol. 21, Iss. 8, 2012-08 ,pp. :
Vandetanib for the treatment of non-small-cell lung cancer
By Wong Hui-li de Boer Richard H
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. :